Dall'Acqua; William

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dall'Acqua; William.The latest application filed is for "humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease".

Company Profile

4.21.52

Dall'Acqua; William - Gaithersburg MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20210061906 - Damschroder; Melissa ; et al.	2021-03-04
Molecules With Altered Neonate Fc Receptor Binding Having Enhanced Therapeutic And Diagnostic Properties App 20200071423 - TSUI; PING ; et al.	2020-03-05
Stabilized angiopoietin-2 antibodies and uses thereof Grant 10,329,345 - Bedian , et al.	2019-06-25
Mrka Polypeptides, Antibodies, And Uses Thereof App 20190062411 - WANG; Qun ; et al.	2019-02-28
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20180273621 - Damschroder; Melissa ; et al.	2018-09-27
Molecules with Reduced Effector Function and Extended Half-Lives, Compositions, and Uses Thereof App 20180258178 - Tsui; Ping ; et al.	2018-09-13
Molecules with reduced effector function and extended half-lives, compositions, and uses thereof Grant 10,011,660 - Tsui , et al. July 3, 2	2018-07-03
Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease Grant 9,896,505 - Damschroder , et al. February 20, 2	2018-02-20
Molecules With Altered Neonate Fc Receptor Binding Having Enhanced Therapeutic And Diagnostic Properties App 20170267780 - TSUI; PING ; et al.	2017-09-21
Stabilized Angiopoietin-2 Antibodies And Uses Thereof App 20170174756 - BEDIAN; VAHE ; et al.	2017-06-22
Human Anti Il-6 Antibodies With Extended In Vivo Half-life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases App 20170101468 - Bowen; Michael ; et al.	2017-04-13
MrkA Polypeptides, Antibodies, and Uses Thereof App 20170073397 - WANG; Qun ; et al.	2017-03-16
Molecules with extended half-lives, compositions and uses thereof Grant 9,562,100 - Dall'Acqua , et al. February 7, 2	2017-02-07
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20160145335 - Damschroder; Melissa ; et al.	2016-05-26
Molecules with Reduced Effector Function and Extended Half-Lives, Compositions, and Uses Thereof App 20150125444 - Tsui; Ping ; et al.	2015-05-07
Molecules With Extended Half-lives, Compositions And Uses Thereof App 20140377181 - Dall'Acqua; William ; et al.	2014-12-25
Humanized anti-CD19 antibodies Grant 8,883,992 - Damschroder , et al. November 11, 2	2014-11-11
Human Anti Il-6 Antibodies With Extended In Vivo Half-life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases App 20140302058 - Bowen; Michael ; et al.	2014-10-09
Molecules with extended half-lives, compositions and uses thereof Grant 8,795,661 - Dall'Acqua , et al. August 5, 2	2014-08-05
Molecules With Extended Half-Lives And Uses Thereof App 20140170142 - LUBMAN; OLGA ; et al.	2014-06-19
Modulation Of Antibody Effector Function By Hinge Domain Engineering App 20140171623 - Dall'Acqua; William ; et al.	2014-06-19
Modulation of antibody effector function by hinge domain engineering Grant 8,697,396 - Dall'Acqua , et al. April 15, 2	2014-04-15
Stabilized Angiopoietin-2 Antibodies And Uses Thereof App 20130280251 - Bedian; Vahe ; et al.	2013-10-24
Molecules With Extended Half-lives, Compositions And Uses Thereof App 20130272964 - DALL'ACQUA; WILLIAM ; et al.	2013-10-17
Stabilized angiopoietin-2 antibodies and uses thereof Grant 8,507,656 - Bedian , et al. August 13, 2	2013-08-13
Molecules with extended half-lives, compositions and uses thereof Grant 8,475,792 - Dall'Acqua , et al. July 2, 2	2013-07-02
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20130115657 - Damschroder; Melissa ; et al.	2013-05-09
Molecules With Extended Half-Lives, Compositions And Uses Thereof App 20130052135 - Dall'Acqua; William ; et al.	2013-02-28
Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease Grant 8,323,653 - Damschroder , et al. December 4, 2	2012-12-04
Molecules with extended half-lives, compositions and uses thereof Grant 8,323,962 - Dall'Acqua , et al. December 4, 2	2012-12-04
Integrated approach for generating multidomain protein therapeutics Grant 8,309,690 - Allan , et al. November 13, 2	2012-11-13
Molecules With Extended Half-lives And Uses Thereof App 20120134984 - Lubman; Olga ; et al.	2012-05-31
Modulation Of Antibody Effector Function By Hinge Domain Engineering App 20120046450 - Dall'Acqua; William ; et al.	2012-02-23
Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases App 20120034212 - Bowen; Michael ; et al.	2012-02-09
Molecules With Extended Half-lives, Compositions And Uses Thereof App 20110311454 - Dall'Acqua; William ; et al.	2011-12-22
Molecules with extended half-lives, compositions and uses thereof Grant 8,012,476 - Dall'Acqua , et al. September 6, 2	2011-09-06
Modulation of antibody effector function by hinge domain engineering Grant 8,008,443 - Dall'Acqua , et al. August 30, 2	2011-08-30
Methods Of Preventing And Treating Rsv Infections And Related Conditions App 20110158985 - LOSONSKY; GENEVIEVE ; et al.	2011-06-30
CRYSTALS AND STRUCTURE OF HUMAN IgG Fc VARIANT App 20110091992 - Dall'Acqua; William ; et al.	2011-04-21
Hinge Domain Engineering App 20110077383 - Dall'Acqua; William ; et al.	2011-03-31
Stabilized Angiopoietin-2 Antibodies And Uses Thereof App 20110044998 - Bedian; Vahe ; et al.	2011-02-24
Methods of Treating RSV Infections And Related Conditions App 20110008329 - Krishnan; Subramaniam ; et al.	2011-01-13
Framework-Shuffling Of Antibodies App 20100216975 - WU; Herren ; et al.	2010-08-26
Molecules With Extended Half-lives, Compositions And Uses Thereof App 20100189718 - Dall'Acqua; William ; et al.	2010-07-29
Molecules With Reduced Half-lives, Compositions And Uses Thereof App 20100143254 - Dall'Acqua; William ; et al.	2010-06-10
Increasing The Production Of Recombinant Antibodies In Mammalian Cells By Site-Directed Mutagenesis App 20100145028 - DALL'ACQUA; William ; et al.	2010-06-10
Integrated Approach For Generating Multidomain Protein Therapeutics App 20100105873 - Allan; Christian ; et al.	2010-04-29
Molecules with extended half-lives, compositions and uses thereof Grant 7,704,497 - Dall'Acqua , et al. April 27, 2	2010-04-27
Methods Of Preventing And Treating Rsv Infections And Related Conditions App 20100098708 - Losonsky; Genevieve ; et al.	2010-04-22
Molecules with extended half-lives, compositions and uses thereof Grant 7,670,600 - Dall'Acqua , et al. March 2, 2	2010-03-02
Molecules with extended half-lives, compositions and uses thereof Grant 7,658,921 - Dall'Acqua , et al. February 9, 2	2010-02-09
Humanization Of Antibodies App 20090297514 - WU; Herren ; et al.	2009-12-03
Modulation Of Antibody Effector Function By Hinge Domain Engineering App 20090221803 - Dall'Acqua; William ; et al.	2009-09-03
Affinity Optimized Epha2 Agonistic Antibodies And Methods Of Use Thereof App 20090220527 - Damschroder; Melissa ; et al.	2009-09-03
Recombinant Anti-Interleukin-9 Antibodies App 20080299134 - Reed; Jennifer Lynne ; et al.	2008-12-04
Molecules with extended half-lives, compositions and uses thereof App 20080181887 - Dall-Acqua; William ; et al.	2008-07-31
Humanized Anti-CD19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20080138336 - Damschroder; Melissa ; et al.	2008-06-12
Recombinant anti-interleukin-9 antibodies Grant 7,371,383 - Reed , et al. May 13, 2	2008-05-13
Molecules with extended half-lives, compositions and uses thereof App 20070122403 - Dall'Acqua; William ; et al.	2007-05-31
Framework-shuffling of antibodies App 20060228350 - Wu; Herren ; et al.	2006-10-12
Molecules with extended half-lives, compositions and uses thereof App 20060198840 - Dall'Acqua; William ; et al.	2006-09-07
Molecules with extended half-lives, compositions and uses thereof Grant 7,083,784 - Dall'Acqua , et al. August 1, 2	2006-08-01
Modulation of antibody specificity by tailoring the affinity to cognate antigens App 20060121042 - Dall'Acqua; William ; et al.	2006-06-08
Methods of preventing and treating RSV infections and related conditions App 20060115485 - Losonsky; Genevieve ; et al.	2006-06-01
Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis App 20060019342 - Dall'Acqua; William ; et al.	2006-01-26
Periplasmic expression of antibodies using a single signal sequence App 20050181479 - Dall'Acqua, William ; et al.	2005-08-18
Humanization of antibodies App 20050048617 - Wu, Herren ; et al.	2005-03-03
Humanization of antibodies App 20050042664 - Wu, Herren ; et al.	2005-02-24
Recombinant anti-interleukin-9 antibodies App 20030219439 - Reed, Jennifer Lynne ; et al.	2003-11-27
Molecules with extended half-lives, compositions and uses thereof App 20030190311 - Dall'Acqua, William ; et al.	2003-10-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.